Cyclerion Therapeutics Stock (NASDAQ:CYCN), Quotes and News Summary

Q: What sector and industry does Cyclerion Therapeutics (CYCN) operate in?

Cyclerion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Cyclerion Therapeutics Stock (NASDAQ: CYCN) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 2.925K
Day Range	- - -
52 Wk Range	1.750 - 6.750
Market Cap	$8.022M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	1.11%
Days to Cover	6.96

Recent News

Why Genesco Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Harbor Custom Development, Inc. (NASDAQ: HCDI) rose 74.2% to $1.50 after surging 24% on Thursday.

Lisa Levin

Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering.

Lisa Levin

Cyclerion Therapeutics to Sell Assets for $81M, CEO Transition To New Spin-Off Private Company Established By Shareholders, New Investors

Cyclerion Therapeutics Inc (NASDAQ: CYCN) has agreed to sell two of its assets - zagociguat (formerly CY6463) and CY3018, to a new private company ("NewCo") formed by certain current Cyclerion shareholders and new investors who have agreed to

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Cyclerion Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of sol...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cyclerion Therapeutics (CYCN) stock?

You can purchase shares of Cyclerion Therapeutics (NASDAQ: CYCN) through any online brokerage.

View our list of the best stock brokerages.

Who are Cyclerion Therapeutics's (CYCN) competitors?

Other companies in Cyclerion Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Can Fite Biofarma (AMEX:CANF), BioRestorative Therapies (NASDAQ:BRTX) and NuCana (NASDAQ:NCNA).

What is the target price for Cyclerion Therapeutics (CYCN) stock?

The latest price target for Cyclerion Therapeutics (NASDAQ: CYCN) was reported by Truist Securities on Wednesday, October 20, 2021. The analyst firm set a price target for 14.00 expecting CYCN to rise to within 12 months (a possible 372.97% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Cyclerion Therapeutics (CYCN)?

The stock price for Cyclerion Therapeutics (NASDAQ: CYCN) is $2.96 last updated April 18, 2024 at 8:26 AM EDT.

Does Cyclerion Therapeutics (CYCN) pay a dividend?

There are no upcoming dividends for Cyclerion Therapeutics.

When is Cyclerion Therapeutics (NASDAQ:CYCN) reporting earnings?

Cyclerion Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.

Is Cyclerion Therapeutics (CYCN) going to split?

There is no upcoming split for Cyclerion Therapeutics.

What sector and industry does Cyclerion Therapeutics (CYCN) operate in?

Cyclerion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-